Literature DB >> 8466283

Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects.

C Lotte1, R C Wester, A Rougier, H I Maibach.   

Abstract

Individual differences exist between patients, and, for topical therapy, differences in skin due to race may be a consideration. Pharmacological response depends upon the percutaneous absorption and the inherent activity of the chemical once absorbed into the biological system. Our objective was to determine the in vivo percutaneous absorption of three test chemicals in human subjects with Asian (A), black (B) and Caucasian (C) ethnic skin. Following a 30 min topical application on the upper outer arm of 1 mumol/cm2 14C-labeled chemical, percutaneous absorption was determined by both urinary excretion and the stripping technique. Amounts absorbed were: for benzoic acid 1.43 +/- 0.27% (SD) (A), 1.07 +/- 0.18% (B), 1.2 +/- 0.19% (C); for caffeine 1.06 +/- 0.17% (A), 1.01 +/- 0.19% (B) and 0.96 +/- 0.12% (C); for acetylsalicylic acid 1.8 +/- 0.31% (A), 1.59 +/- 0.31% (B) and 2.12 +/- 0.36% (C). No statistical difference (P > 0.05) was found in percutaneous absorption of benzoic acid, caffeine or acetylsalicylic acid between Asian, black and Caucasian subjects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466283     DOI: 10.1007/bf00373356

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  Studies on the chemical composition of human epidermal lipids.

Authors:  R P REINERTSON; V R WHEATLEY
Journal:  J Invest Dermatol       Date:  1959-01       Impact factor: 8.551

2.  Racial differences in sodium lauryl sulphate induced cutaneous irritation: black and white.

Authors:  E Berardesca; H I Maibach
Journal:  Contact Dermatitis       Date:  1988-02       Impact factor: 6.600

3.  Cutaneous responses to topical methyl nicotinate in black, oriental, and caucasian subjects.

Authors:  C J Gean; E Tur; H I Maibach; R H Guy
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Are there age and racial differences to methyl nicotinate-induced vasodilatation in human skin?

Authors:  R H Guy; E Tur; S Bjerke; H I Maibach
Journal:  J Am Acad Dermatol       Date:  1985-06       Impact factor: 11.527

5.  Regional variation in percutaneous absorption in man: measurement by the stripping method.

Authors:  A Rougier; D Dupuis; C Lotte; R Roguet; R C Wester; H I Maibach
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 6.  Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.

Authors:  R C Wester; H I Maibach
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

7.  Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results.

Authors:  R L Bronaugh; R F Stewart; E R Congdon; A L Giles
Journal:  Toxicol Appl Pharmacol       Date:  1982-03-15       Impact factor: 4.219

8.  Regional variation in percutaneous penetration of 14C cortisol in man.

Authors:  R J Feldmann; H I Maibach
Journal:  J Invest Dermatol       Date:  1967-02       Impact factor: 8.551

9.  Percutaneous penetration of dipyrithione in man: effect of skin color (race).

Authors:  J H Wedig; H I Maibach
Journal:  J Am Acad Dermatol       Date:  1981-10       Impact factor: 11.527

10.  Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin.

Authors:  R L Bronaugh; R F Stewart; M Simon
Journal:  J Pharm Sci       Date:  1986-11       Impact factor: 3.534

View more
  2 in total

1.  Modern Intermittent Haemodialysis (IHD) is an Effective Method of Removing Salicylate in Chronic Topical Salicylate Toxicity.

Authors:  Anselm Wong; Kathy Mac; Anders Aneman; Jeffrey Wong; Betty S Chan
Journal:  J Med Toxicol       Date:  2016-03

2.  IcyHot analgesic topical cream limits cardiac injury in rodents.

Authors:  Yun Wu; Annabel W Chen; Candida L Goodnough; Yao Lu; Ye Zhang; Eric R Gross
Journal:  Transl Res       Date:  2020-07-03       Impact factor: 7.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.